Analyst Price Target is $0.75
▲ +244.99% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Cannabist in the last 3 months. The average price target is $0.75, with a high forecast of $0.75 and a low forecast of $0.75. The average price target represents a 244.99% upside from the last price of $0.22.
Current Consensus is
Moderate Buy
The current consensus among 2 polled investment analysts is to moderate buy stock in Cannabist. This rating has held steady since August 2024, when it changed from a Buy consensus rating.
Cannabist
The Cannabist Company Holdings Inc. engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. The company provides flower, concentrates, edibles, and/or accesories, and medicinal cannabinoid capsules and tablets, as well as confections, chocolate, drink mixes, condiments, kief, shatter, and wax/crumble, under the Seed & Strain, Classix, and Triple Seven brand names. It offers management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in New York, New York.
Read More